A Randomised Controlled Trial of Ibuprofen, Paracetamol or a Combination Tablet of Ibuprofen/paracetamol in Community-derived People with Knee Pain
Overview
Affiliations
Objectives: To compare the efficacy and safety of single versus combination non-prescription oral analgesics in community-derived people aged 40 years and older with chronic knee pain.
Methods: A randomised, double-blind, four-arm, parallel-group, active controlled trial investigating short-term (day 10) and long-term (week 13) benefits and side-effects of four regimens, each taken three times a day: ibuprofen (400 mg); paracetamol (1000 mg); one fixed-dose combination tablet (ibuprofen 200 mg/paracetamol 500 mg); two fixed-dose combination tablets (ibuprofen 400 mg/paracetamol 1000 mg).
Results: There were 892 participants (mean age 60.6, range 40-84 years); 63% had radiographic knee osteoarthritis and 85% fulfilled American College of Rheumatology criteria for osteoarthritis. At day 10, two combination tablets were superior to paracetamol (p<0.01) for pain relief (determined by mean change from baseline in WOMAC pain; n=786). At 13 weeks, significantly more participants taking one or two combination tablets rated their treatment as excellent/good compared with paracetamol (p=0.015, p=0.0002, respectively; n=615). The frequency of adverse events was comparable between groups. However, by 13 weeks, decreases in haemoglobin (≥1 g/dl) were observed in some participants in all groups. Twice as many participants taking two combination tablets had this decrease compared with those on monotherapy (p<0.001; paracetamol, 20.3%; ibuprofen, 19.6%; one or two combination tablets, 24.1%, 38.4%, respectively).
Conclusions: Ibuprofen/paracetamol combination analgesia, at non-prescription doses, confers modest short-term benefits for knee pain/osteoarthritis. However, in this population, paracetamol 3 g/day may cause similar degrees of blood loss as ibuprofen 1200 mg/day, and the combination of the two appears to be additive. Study no ISRCTN77199439.
Therapeutic Efficacy of Medicinal Plants with Allopathic Medicine in Musculoskeletal Diseases.
Rajalekshmi R, Agrawal D Int J Plant Anim Environ Sci. 2025; 14(4):104-129.
PMID: 39866300 PMC: 11765655. DOI: 10.26502/ijpaes.4490170.
Efficacy and Safety of Fixed-Dose Combinations for Pain in Older Adults.
Zhang Q, Chan D, Ho K Drugs Aging. 2024; 41(11):873-879.
PMID: 39453601 DOI: 10.1007/s40266-024-01156-3.
Cao Z, Han K, Lu H, Illangamudalige S, Abdel Shaheed C, Chen L Drugs. 2024; 84(8):953-967.
PMID: 38937394 PMC: 11343817. DOI: 10.1007/s40265-024-02065-w.
Petersen K, Kilic K, Hertel E, Sejersgaard-Jacobsen T, Jorgensen M, Troelsen A Pain Rep. 2024; 8(4):e1079.
PMID: 38699564 PMC: 11065125. DOI: 10.1097/PR9.0000000000001079.
Sethi V, Qin L, Cox E, Troconiz I, Della Pasqua O Pain Ther. 2024; 13(1):145-159.
PMID: 38183573 PMC: 10796861. DOI: 10.1007/s40122-023-00569-z.